2.4 C
Tuesday, February 7, 2023
- Advertisement -spot_img



Is It Worth Waiting For Novavax’s (NASDAQ: NVAX) Vaccine Candidate?

Novavax Inc. (NASDAQ: NVAX) is preparing to get authorization for its coronavirus vaccine. The firm is currently near the finish line and will soon...

Novavax (NASDAQ: NVAX) Strikes 51M COVID Vaccine Doses Deal With Australia

Novavax, Inc. (NASDAQ: NVAX) has completed the COVID-19 vaccine supply deal with the Commonwealth of Australia. As per the deal, Novavax is scheduled to...

Novavax (NASDAQ: NVAX) Announces Delay In Coronavirus Trial

Novavax, Inc. (NASDAQ: NVAX) has provided updates regarding its late-stage coronavirus study. The company has disclosed that it is planning to commence Phase III...

Latest news

- Advertisement -spot_img